EyePoint Pharmaceuticals financials at a glance

+ Portfolio

The revenue of EyePoint Pharmaceuticals is reported as 0.04602 billion Dollars in the fiscal year 2023. The earnings were -0.33 Dollars per share in 2023, which was 84.58 higher than 2022. And about -0.00108 billion Dollars are reported as free cash flow in the financials of EyePoint Pharmaceuticals 2023. No dividends were paid to the shareholders of the EyePoint Pharmaceuticals stock NasdaqGM:EYPT in the financial year 2023.

$46.02M

Revenue

$-0.33

Earnings Per Share

-49.93%

Gross Margin %

$-19.07M

Free Cash Flow

Revenue

46.02

Earnings Per Share

-0.33

Gross Margin %

-49.93

Free Cash Flow

-19.07

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2013	2012	2011	2010
Rev.	Revenue	N/A	$46.02M	$41.40M	$36.94M	$34.44M	$20.37M	$2.96M	$2.14M	$3.53M	$4.97M	$23.05M
GM %	Gross Margin %	-59.82%	-49.93%	-37.35%	0.71%	32.49%	11.34%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	-,192.25%	-,160.52%	-,190.65%	-,149.64%	-,106.57%	-,235.02%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-2.66	$-0.33	$-2.14	$-2.10	$-3.47	$-5.08	$-5.82	$-5.20	$-4.81	$-4.40	$4.60
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	49.83M	34.3M	34.04M	28.74M	12.47M	9.54M	2.68M	2.33M	2.08M	1.85M
OCF	Operating Cash Flow	N/A	$1.88M	$-65.01M	$-50.10M	$-14.44M	$-56.70M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$-19.07M	$-67.16M	$-50.25M	$-14.80M	$-56.91M	$-22.02M	$0.00M	$0.00M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$0.24	$-0.04	$-1.80	$-1.75	$-1.15	$-0.55	$-0.50	$0.00	$0.00	$0.00	$0.00

EyePoint Pharmaceuticals financials at a glance

Financials

Discover